相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First human dose (FHD) study of the oral transforming growth factor-beta receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma.
J. Rodon Ahnert et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
N. Rainusso et al.
CANCER GENE THERAPY (2012)
Development of murine models of breast cancer metastasis for the evaluation of the efficacy of TGF-β inhibitors as therapeutic agents
Tanuka Biswas et al.
CANCER RESEARCH (2012)
Microenvironmental signals dictate disseminated tumor cells (DTCs) fate through regulation of TGFβII and p38α
Paloma Bragado et al.
CANCER RESEARCH (2012)
Long-term survival in a phase II atudy of belagenpumatucel-L (TGF-13 antisense modified tumor cell vaccine) in non-small cell lung cancer (NSCLC).
Lyudmila Bazhenoya et al.
CANCER RESEARCH (2012)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Skin Tumors Induced by Sorafenib; Paradoxic RAS-RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1
Jean Philippe Arnault et al.
CLINICAL CANCER RESEARCH (2012)
Management of Idiopathic Pulmonary Fibrosis
Stefania Cerri et al.
CLINICS IN CHEST MEDICINE (2012)
TGFβ Signaling and Cardiovascular Diseases
Evangelia Pardali
International Journal of Biological Sciences (2012)
Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice
Megan Podowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy
Yanan Liu et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
Gloria B. Roldan Urgoiti et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Stromedix acquisition signals growing interest in fibrosis
Malorye Allison
NATURE BIOTECHNOLOGY (2012)
The paradoxical TGF-β vasculopathies
Rosemary J. Akhurst
NATURE GENETICS (2012)
DEAL WATCH Biogen acquires Stromedix to pursue novel fibrosis therapy
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia
Michael Benzinou et al.
NATURE COMMUNICATIONS (2012)
Pirfenidone treatment of idiopathic pulmonary fibrosis
Arata Azuma
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Blockade of TSP1-Dependent TGF-β Activity Reduces Renal Injury and Proteinuria in a Murine Model of Diabetic Nephropathy
Ailing Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis
Harold A. Chapman
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney
Cabir Alan et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
Michael Quante et al.
CANCER CELL (2011)
Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase
Li Zhou et al.
CANCER RESEARCH (2011)
Mcl-1 downregulation plays a crucial role in the synergistic anticancer activities between PI-3 kinase inhibitors and histone deacetylase inhibitors in primary NSCLC tumors in vitro and in vivo
Hao Zhang et al.
CANCER RESEARCH (2011)
Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
Mengxian Zhang et al.
CANCER RESEARCH (2011)
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
Karl-Hermann Schlingensiepen et al.
CANCER SCIENCE (2011)
Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling
Hariom Yadav et al.
CELL METABOLISM (2011)
TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
Fanny Bouquet et al.
CLINICAL CANCER RESEARCH (2011)
Long-term Follow-up After Lamellar Keratoplasty in a Patient With Bilateral Idiopathic Corneal Keloid
Ken Fukuda et al.
CORNEA (2011)
Antibody Targeting of TGF-β in Cancer Patients
Scott Lonning et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Mouse T helper 17 phenotype: Not so different than in man after all
Francesco Annunziato et al.
CYTOKINE (2011)
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis
Laura Arribillaga et al.
CYTOKINE (2011)
Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo
Andrea Conidi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Hai Yong Chen et al.
DIABETES (2011)
Exploring anti-TGF-ββ therapies in cancer and fibrosis
Lukas J. A. C. Hawinkels et al.
GROWTH FACTORS (2011)
Autocrine Transforming Growth Factor-β1 Promotes In Vivo Th17 Cell Differentiation
Ilona Gutcher et al.
IMMUNITY (2011)
Diverse Roles of TGF-beta/Smads in Renal Fibrosis and Inflammation
Hui Yao Lan
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Epithelial-mesenchymal transition in renal fibrosis - evidence for and against
Maria Fragiadaki et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
Stephanie A. McClymont et al.
JOURNAL OF IMMUNOLOGY (2011)
Transcriptional Inhibition of Hypertrophic Scars by a Gene Silencer, Pyrrole-Imidazole Polyamide, Targeting the TGF-β1 Promoter
Hisayo Washio et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts
Navin K. Kapur et al.
JOURNAL OF VASCULAR SURGERY (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor
Yozo Nakazawa et al.
MOLECULAR THERAPY (2011)
Latent TGF-β structure and activation
Minlong Shi et al.
NATURE (2011)
Gene therapy finds its niche
Cormac Sheridan
NATURE BIOTECHNOLOGY (2011)
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1
David R. Goudie et al.
NATURE GENETICS (2011)
Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3
Takashi Maruyama et al.
NATURE IMMUNOLOGY (2011)
Targeted therapy for high-grade glioma with the TGF-beta 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
U. Bogdahn et al.
NEURO-ONCOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells
S. Ehata et al.
ONCOGENE (2011)
Interaction of TGFβ and BMP Signaling Pathways during Chondrogenesis
Bettina Keller et al.
PLOS ONE (2011)
Smad-mediated miRNA processing A critical role for a conserved RNA sequence
Brandi N. Davis-Dusenbery et al.
RNA BIOLOGY (2011)
Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
Tammy M. Holm et al.
SCIENCE (2011)
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Mark J. Anderton et al.
TOXICOLOGIC PATHOLOGY (2011)
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring
Nick L. Occleston et al.
WOUND REPAIR AND REGENERATION (2011)
Blocking TGF beta via Inhibition of the alpha v beta 6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease
Tamiko R. Katsumoto et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2011)
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
Hiroyuki Taniguchi et al.
RESPIRATORY RESEARCH (2011)
Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction
Sih Min Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
Judit Anido et al.
CANCER CELL (2010)
Combination effect of a TGF-β receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice
Osamu Shinto et al.
CANCER SCIENCE (2010)
Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor beta-Insensitive CD8(+) T Cells
Longxin Wang et al.
CLINICAL CANCER RESEARCH (2010)
Anti-Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
Zhaojing Zhong et al.
CLINICAL CANCER RESEARCH (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice
Andrew C. Melton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
αv Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice
Mridu Acharya et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter
Adele Hannigan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Angiotensin II sustains brain inflammation in mice via TGF-β
Tobias V. Lanz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Effects of Avotermin (Transforming Growth Factor β3) in a Clinically Relevant Pig Model of Long, Full-Thickness Incisional Wounds
Hugh G. Laverty et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2010)
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
Vidya Ganapathy et al.
MOLECULAR CANCER (2010)
Pretranscriptional Regulation of Tgf-β1 by PI Polyamide Prevents Scarring and Accelerates Wound Healing of the Cornea After Exposure to Alkali
Min Chen et al.
MOLECULAR THERAPY (2010)
TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
Kazuhito Naka et al.
NATURE (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
Kyoko Takeuchi et al.
PLOS ONE (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
Ryan B. Corcoran et al.
SCIENCE SIGNALING (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
TGF-β through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation
Shirling Tsai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
Silvia Penuelas et al.
CANCER CELL (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
J. Nemunaitis et al.
CANCER GENE THERAPY (2009)
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
Bixiang Zhang et al.
CANCER LETTERS (2009)
A pyrrole-imidazole polyamide targeting transforming growth factor-β1 inhibits restenosis and preserves endothelialization in the injured artery
En-Hui Yao et al.
CARDIOVASCULAR RESEARCH (2009)
A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
Nerea Hermida et al.
CARDIOVASCULAR RESEARCH (2009)
Gain or loss of TGFβ signaling in mammary carcinoma cells can promote metastasis
Brian Bierie et al.
CELL CYCLE (2009)
Transforming growth factor beta (TGF beta)-induced apoptosis The rise & fall of Bim
Sneha Ramesh et al.
CELL CYCLE (2009)
Signaling cross-talk between TGF-beta/BMP and other pathways
Xing Guo et al.
CELL RESEARCH (2009)
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
Hiroaki Ikushima et al.
CELL STEM CELL (2009)
Searching for MiR-acles in Cardiac Fibrosis
Eva van Rooij et al.
CIRCULATION RESEARCH (2009)
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition
Carl-Henrik Heldin et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Strategies for TGF-β modulation: a review of recent patents
Dominique Bonafoux et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease
P. Ranjzad et al.
GENE THERAPY (2009)
Inhibition of Transforming Growth Factor β Receptor I Kinase Blocks Hepatocellular Carcinoma Growth Through Neo-angiogenesis Regulation
Antonio Mazzocca et al.
HEPATOLOGY (2009)
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
Diana Llopiz et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer
Brian Bierie et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
Douglas S. Micalizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
Jean Philippe Arnault et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation
Jyoti Das et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Transforming growth factor-β in breast cancer: too much, too late
Mary Helen Barcellos-Hoff et al.
BREAST CANCER RESEARCH (2009)
SM16, an orally active TGF-β type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model
Kai Fu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A. Merkel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
TGF-β signalling-related markers in cancer patients with bone metastasis
Jose Baselga et al.
BIOMARKERS (2008)
Antibody-mediated blockade of integrin αvβ6 inhibits tumor progression in vivo by a transforming growth factor-β-regulated mechanism
Louise A. Koopman Van Aarsen et al.
CANCER RESEARCH (2008)
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Samuel Kim et al.
CANCER RESEARCH (2008)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Transforming growth factor-β receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers
Africa Wallace et al.
CLINICAL CANCER RESEARCH (2008)
Acquired resistance to tyrosine kinase inhibitors during cancer therapy
Jeffrey A. Engelman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Activin/TGFβ and BMP crosstalk determines digit chondrogenesis
Juan A. Montero et al.
DEVELOPMENTAL BIOLOGY (2008)
Smad7 gene transfer therapy: therapeutic applications beyond colonic fibrosis
Shailendra Kapoor
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
Emilia Fransvea et al.
HEPATOLOGY (2008)
Small molecular inhibitor of transforming growth factor-β protects against development of radiation-induced lung injury
Mitchell S. Anscher et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Autoimmune Hemolytic Anemia Associated With Ovarian Cancer
Patrick G. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
M. Petersen et al.
KIDNEY INTERNATIONAL (2008)
LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Davide Melisi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Transforming Growth Factor β-Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis?
Marie-Jose Goumans et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
TGFβ-SMAD signal transduction:: molecular specificity and functional flexibility
Bernhard Schmierer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
A phase III study of subconjunctival human anti-transforming growth factor β2 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
Robert Vogel
OPHTHALMOLOGY (2007)
Transforming growth factor-β can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model
Binwu Tang et al.
CANCER RESEARCH (2007)
Differentiation plasticity regulated by TGF-β family proteins in development and disease
Rik Derynck et al.
NATURE CELL BIOLOGY (2007)
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis
Mizuho Yamada et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
TGFβ signalling in control of T-cell-mediated self-reactivity
Yuri P. Rubtsov et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Marfan syndrome: from molecular pathogenesis to clinical treatment
Francesco Ramirez et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment
Sylvaine You et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection
Eiji Suzuki et al.
CANCER RESEARCH (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling
Mitsunobu R. Kano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
Ronald D. Cohn et al.
NATURE MEDICINE (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
Development and validation of a phosphorylated SMAD ex vivo stimulation assay
D. L. Farrington et al.
BIOMARKERS (2007)
Inhibition of ALK5 signaling induces physeal dysplasia in rats
Kendall Frazier et al.
TOXICOLOGIC PATHOLOGY (2007)
Inhibition of transforming growth factor-β1 signaling attenuates ataxia telanglectasia mutated activity in response to genotoxic stress
Julia Kirshner et al.
CANCER RESEARCH (2006)
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer
John Nemunaitis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells
Roger R. Gomis et al.
CANCER CELL (2006)
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Kevin K. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A FoxO-Smad synexpression group in human keratinocytes
Roger R. Gomis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo
Rongrong Ge et al.
CLINICAL CANCER RESEARCH (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle
Qiang Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
δEF1 mediates TGF-β signaling in vascular smooth muscle cell differentiation
Go Nishimura et al.
DEVELOPMENTAL CELL (2006)
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor β in a mouse model of breast cancer
Jeong-Seok Nam et al.
CANCER RESEARCH (2006)
Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility
Jian-Hua Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The logic of TGFβ signaling
Joan Massague et al.
FEBS LETTERS (2006)
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
Shi-Long Lu et al.
GENES & DEVELOPMENT (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H-pyran-4-yl)benzamide (GW788388):: A potent, selective, and orally active transforming growth factor-β type I receptor inhibitor
F Gellibert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
KH Schlingensiepen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
L Levy et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Renal fibrosis: New insights into the pathogenesis and therapeutics
YH Liu
KIDNEY INTERNATIONAL (2006)
Protein tyrosine phosphatases, new targets for cancer therapy
David Easty et al.
CURRENT CANCER DRUG TARGETS (2006)
Mutations of TGF beta signaling molecules in human disease
Kelly A. Harradine et al.
ANNALS OF MEDICINE (2006)
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts
H Zhou et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis
B Santiago et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ
Y Laouar et al.
NATURE IMMUNOLOGY (2005)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma
AV Salnikov et al.
LABORATORY INVESTIGATION (2005)
Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: Toxicology and safety
R Schlingensiepen et al.
OLIGONUCLEOTIDES (2005)
SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7
SD Byfield et al.
MOLECULAR PHARMACOLOGY (2004)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Intimal hyperplasia and expression of transforming growth factor-β1 saphenous veins and internal mammary arteries before coronary artery surgery
R Friedl et al.
ANNALS OF THORACIC SURGERY (2004)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Transforming growth factor β receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment
T Hayashi et al.
CLINICAL CANCER RESEARCH (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-β-mediated epithelial cell growth suppression
PM Siegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evaluation of anti-TGF-β2 antibody as a new postoperative anti-scarring agent in glaucoma surgery
AL Mead et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury
IJ Ezquerro et al.
CYTOKINE (2003)
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
ER Neptune et al.
NATURE GENETICS (2003)
Targeted disruption of TGF-beta 1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
M Sato et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Rapamycin potentiates transforming growth factor β-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells
BK Law et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Human antitransforming growth factor beta(2) monoclonal antibody - A new modulator of wound healing in trabeculectomy - A randomized placebo controlled clinical study
D Siriwardena et al.
OPHTHALMOLOGY (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-β release and reduces migration and invasiveness of human malignant glioma cells
M Platten et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice
J Larsson et al.
EMBO JOURNAL (2001)
Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
DS Lim et al.
CIRCULATION (2001)
How cells read TGF-β signals
J Massagué
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts
M Isaji et al.
CORNEA (2000)
TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors
K Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
